Controlled release formulations using intelligent polymers

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 31/35 (2006.01)

Patent

CA 2732093

A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent polymer component having opposite wettability characteristics to the first intelligent polymer component. The polymer components are effective for controlled release of the pharmaceutically active substance from the composition.

L'invention porte sur une composition pharmaceutique à libération contrôlée qui comprend (a) du topiramate ou un sel pharmaceutiquement acceptable de celui-ci, (b) un premier composant polymère intelligent; et (c) un second composant polymère intelligent ayant des caractéristiques de mouillabilité opposées au premier composant polymère intelligent. Les composants polymères sont efficaces pour une libération contrôlée de la substance pharmaceutiquement active à partir de la composition.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Controlled release formulations using intelligent polymers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulations using intelligent polymers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulations using intelligent polymers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1399318

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.